MiR-940 is a New Biomarker with Tumor Diagnostic and Prognostic Value

Overview

Journal Mol Ther Nucleic Acids

Publisher Cell Press

Date 2021 Jun 25

PMID 34168918

Citations 14

Authors

Hongxiang Li

Yin Li

Dongmei Tian

Jiaqian Zhang

Shiwei Duan

Affiliations

Soon will be listed here.

Abstract

miR-940 is a microRNA located on chromosome 16p13.3, which has varying degrees of expression imbalance in many diseases. It binds to the 3' untranslated region (UTR) and affects the transcription or post-transcriptional regulation of target protein-coding genes. For a diversity of cellular processes, including cell proliferation, migration, invasion, apoptosis, epithelial-to-mesenchymal transition (EMT), cell cycle, and osteogenic differentiation, miR-940 can affect them not only by regulating protein-coding genes but also long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) in pathways. Intriguingly, miR-940 participates in four pathways that affect cancer development, including the Wnt/β-catenin pathway, mitogen-activated protein kinase (MAPK) pathway, PD-1 pathway, and phosphatidylinositol 3-kinase (PI3K)-Akt pathway. Importantly, the expression of miR-940 is intimately correlated with the diagnosis and prognosis of tumor patients, as well as to the efficacy of tumor chemotherapy drugs. In conclusion, our main purpose is to outline the expression of miR-940 in various diseases and the molecular biological and cytological functions of target genes in order to reveal its potential diagnostic and prognostic value as well as its predictive value of drug efficacy.

Citing Articles

Exploring miRNA therapies and gut microbiome-enhanced CAR-T cells: advancing frontiers in glioblastoma stem cell targeting.

Sandhanam K, Tamilanban T, Bhattacharjee B, Manasa K Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39382681 DOI: 10.1007/s00210-024-03479-9.

Circ_0006174 Upregulates IGF1R to Enhance Radioresistance and Tumorigenesis in Colorectal Cancer via miR-940 Suppression.

Zhang X, Fang F, Zhang J, Zhang S, Li H, Li B Appl Biochem Biotechnol. 2024; 197(1):497-517.

PMID: 39172343 DOI: 10.1007/s12010-024-05028-9.

Current and future perspectives on the regulation and functions of miR-545 in cancer development.

Shen J, Su X, Wang Q, Ke Y, Zheng T, Mao Y Cancer Pathog Ther. 2024; 2(3):142-154.

PMID: 39027151 PMC: 11252520. DOI: 10.1016/j.cpt.2023.09.001.

The role of miRNAs as biomarkers in breast cancer.

Baylie T, Kasaw M, Getinet M, Getie G, Jemal M, Nigatu A Front Oncol. 2024; 14:1374821.

PMID: 38812786 PMC: 11133523. DOI: 10.3389/fonc.2024.1374821.

miR-940 modulates CD47 to suppress biological functions of lung adenocarcinoma cells.

Long S, Long X, Guo J, Fu L, Huang X, Liu H Am J Cancer Res. 2024; 14(3):1157-1173.

PMID: 38590419 PMC: 10998766. DOI: 10.62347/YYJN3674.

References

Wang T, Liu X, Tian Q, Liang T, Chang P . Reduced SPOCK1 expression inhibits non-small cell lung cancer cell proliferation and migration through Wnt/β-catenin signaling. Eur Rev Med Pharmacol Sci. 2018; 22(3):637-644. DOI: 10.26355/eurrev_201802_14288. View

Chen C, Ridzon D, Broomer A, Zhou Z, Lee D, Nguyen J . Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005; 33(20):e179. PMC: 1292995. DOI: 10.1093/nar/gni178. View

Sun D, Chen L, Lv H, Gao Y, Liu X, Zhang X . Circ_0058124 Upregulates MAPK1 Expression to Promote Proliferation, Metastasis and Metabolic Abilities in Thyroid Cancer Through Sponging miR-940. Onco Targets Ther. 2020; 13:1569-1581. PMC: 7037104. DOI: 10.2147/OTT.S237307. View

Pascut D, Krmac H, Gilardi F, Patti R, Calligaris R, Croce L . A comparative characterization of the circulating miRNome in whole blood and serum of HCC patients. Sci Rep. 2019; 9(1):8265. PMC: 6547851. DOI: 10.1038/s41598-019-44580-x. View

Krek A, Grun D, Poy M, Wolf R, Rosenberg L, Epstein E . Combinatorial microRNA target predictions. Nat Genet. 2005; 37(5):495-500. DOI: 10.1038/ng1536. View

Chen Q, Qiu X . [Bioinformatics on vascular invasion markers in hepatocellular carcinoma via Big-Data analysis]. Zhonghua Liu Xing Bing Xue Za Zhi. 2017; 38(4):522-527. DOI: 10.3760/cma.j.issn.0254-6450.2017.04.022. View

Zhu G, Cheng Z, Huang Y, Zheng W, Yang S, Lin C . MyD88 mediates colorectal cancer cell proliferation, migration and invasion via NF‑κB/AP‑1 signaling pathway. Int J Mol Med. 2019; 45(1):131-140. PMC: 6889924. DOI: 10.3892/ijmm.2019.4390. View

Ju H, Lu Y, Chen D, Zuo Z, Liu Z, Wu Q . Modulation of Redox Homeostasis by Inhibition of MTHFD2 in Colorectal Cancer: Mechanisms and Therapeutic Implications. J Natl Cancer Inst. 2018; 111(6):584-596. PMC: 6579745. DOI: 10.1093/jnci/djy160. View

Zhang J, Shao N, Yang X, Xie C, Shi Y, Lin Y . Interleukin-8 Promotes Epithelial-to-Mesenchymal Transition via Downregulation of Mir-200 Family in Breast Cancer Cells. Technol Cancer Res Treat. 2020; 19:1533033820979672. PMC: 7724258. DOI: 10.1177/1533033820979672. View

10.

Liu X, Ge X, Zhang Z, Zhang X, Chang J, Wu Z . MicroRNA-940 promotes tumor cell invasion and metastasis by downregulating ZNF24 in gastric cancer. Oncotarget. 2015; 6(28):25418-28. PMC: 4694841. DOI: 10.18632/oncotarget.4456. View

11.

Zhu Y, He D, Bo H, Liu Z, Xiao M, Xiang L . The MRVI1-AS1/ATF3 signaling loop sensitizes nasopharyngeal cancer cells to paclitaxel by regulating the Hippo-TAZ pathway. Oncogene. 2019; 38(32):6065-6081. DOI: 10.1038/s41388-019-0858-7. View

12.

Zeng X, Cao Z, Luo W, Zheng L, Zhang T . MicroRNA-381-A Key Transcriptional Regulator: Its Biological Function and Clinical Application Prospects in Cancer. Front Oncol. 2020; 10:535665. PMC: 7726430. DOI: 10.3389/fonc.2020.535665. View

13.

Cheng R, Gao S, Hu W, Liu Y, Cao Y . Nuclear factor I/B mediates epithelial-mesenchymal transition in human melanoma cells through ZEB1. Oncol Lett. 2020; 21(2):81. PMC: 7723069. DOI: 10.3892/ol.2020.12342. View

14.

Gu G, Zhan Y, Abuduwaili K, Wang X, Li X, Zhu H . MiR-940 inhibits the progression of NSCLC by targeting FAM83F. Eur Rev Med Pharmacol Sci. 2018; 22(18):5964-5971. DOI: 10.26355/eurrev_201809_15927. View

15.

Shi J, Wang Y, Sun C, Qin B, Zhang Y, Chen G . Long noncoding RNA lncHERG promotes cell proliferation, migration and invasion in glioblastoma. Oncotarget. 2018; 8(64):108031-108041. PMC: 5746123. DOI: 10.18632/oncotarget.22446. View

16.

Luo H, Xu R, Chen B, Dong S, Zhou F, Yu T . MicroRNA-940 inhibits glioma cells proliferation and cell cycle progression by targeting CKS1. Am J Transl Res. 2019; 11(8):4851-4865. PMC: 6731435. View

17.

Okuwa H, Kanno T, Fujita Y, Gotoh A, Tabata C, Fukuoka K . Sphingosine suppresses mesothelioma cell proliferation by inhibiting PKC-δ and inducing cell cycle arrest at the G(0)/G(1) phase. Cell Physiol Biochem. 2012; 30(4):995-1004. DOI: 10.1159/000341476. View

18.

Ma L, Wang H, Sun Y, Yang D, Pu L, Zhang X . P53-induced MRVI1 mediates carcinogenesis of colorectal cancer. Scand J Gastroenterol. 2020; 55(7):824-833. DOI: 10.1080/00365521.2020.1782465. View

19.

Ding D, Zhang Y, Yang R, Wang X, Ji G, Huo L . miR-940 Suppresses Tumor Cell Invasion and Migration via Regulation of CXCR2 in Hepatocellular Carcinoma. Biomed Res Int. 2016; 2016:7618342. PMC: 5078634. DOI: 10.1155/2016/7618342. View

20.

Nilsson R, Jain M, Madhusudhan N, Gustafsson Sheppard N, Strittmatter L, Kampf C . Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer. Nat Commun. 2014; 5:3128. PMC: 4106362. DOI: 10.1038/ncomms4128. View